Page last updated: 2024-11-04

sibutramine and Syncope

sibutramine has been researched along with Syncope in 2 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research Excerpts

ExcerptRelevanceReference
"Other IMMP case reports suggesting arrhythmias associated with sibutramine were assessed and further reports were obtained from the World Health Organisation (WHO) adverse drug reactions database."1.33QT interval prolongation associated with sibutramine treatment. ( Clark, DW; Harrison-Woolrych, M; Hill, GR; Rees, MI; Skinner, JR, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harrison-Woolrych, M1
Clark, DW1
Hill, GR1
Rees, MI1
Skinner, JR1
Schroeder, C1
Birkenfeld, AL1
Mayer, AF1
Tank, J1
Diedrich, A1
Luft, FC1
Jordan, J1

Trials

1 trial available for sibutramine and Syncope

ArticleYear
Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
    Journal of the American College of Cardiology, 2006, Aug-01, Volume: 48, Issue:3

    Topics: Blood Pressure; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Head-Down Tilt; Heart Rate; H

2006

Other Studies

1 other study available for sibutramine and Syncope

ArticleYear
QT interval prolongation associated with sibutramine treatment.
    British journal of clinical pharmacology, 2006, Volume: 61, Issue:4

    Topics: Adult; Amino Acid Substitution; Appetite Depressants; Arrhythmias, Cardiac; Cyclobutanes; Electrocar

2006